TRPX
Therapix Biosciences Ltd.

5,751
Loading...
Loading...
Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Givatayim, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
11

Frequently Asked Questions

What is Market Cap of Therapix Biosciences Ltd - ADR?
What is the 52-week high for Therapix Biosciences Ltd - ADR?
What is the 52-week low for Therapix Biosciences Ltd - ADR?
What was Therapix Biosciences Ltd - ADR stock price yesterday?
What is the PE ratio of Therapix Biosciences Ltd - ADR?
What is the Price-to-Book ratio of Therapix Biosciences Ltd - ADR?
What is Therapix Biosciences Ltd - ADR's EBITDA?
What is the 50-day moving average of Therapix Biosciences Ltd - ADR?
How many employess does Therapix Biosciences Ltd - ADR has?

Latest TRPX News

View
No TRPX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.